'novel oral drug delivery system for the treatment of allergic asthma'

摘要

The present invention relates to an orally disintegrating tablet comprising a therapeutically effective amount of methylxanthine derivative provided in a sustained release dosage form and a therapeutically effective amount of an antihistamine selected from second generation and third-generation histamine HI receptor antagonist in an immediate release form The invention also provides process of preparation of orally disintegrating tablet.